Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Y Chen

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Nature Immunology|November 29, 2017
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapyAmira A Barkal, Kipp Weiskopf, Kevin S Kao, et al.
The New England Journal of Medicine|November 1, 2018
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's LymphomaRanjana Advani, Ian Flinn, Leslie Popplewell, et al.
Cell|January 17, 2015
Identification and specification of the mouse skeletal stem cellCharles K F Chan, Eun Young Seo, James Y Chen, et al.
The Lancet. Neurology|July 29, 2018
Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational studyJeffrey J Bazarian, Peter Biberthaler, Robert D Welch, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
CD8<sup>+</sup> T cell recall cytotoxicity during chronic treated HIV-1 infection is associated with limited reservoir size and activityDavid R Collins, Mpho J Olatotse, Jonathan M Urbach, et al.
Blood Cancer Discovery|October 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor CellsAnnika Nelde, Heiko Schuster, Jonas S Heitmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 17, 2013
Clonal precursor of bone, cartilage, and hematopoietic niche stromal cellsCharles K F Chan, Paul Lindau, Wen Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced CancersBranimir I Sikic, Nehal Lakhani, Amita Patnaik, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Nature Immunology|November 29, 2017
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapyAmira A Barkal, Kipp Weiskopf, Kevin S Kao, et al.
The New England Journal of Medicine|November 1, 2018
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's LymphomaRanjana Advani, Ian Flinn, Leslie Popplewell, et al.
Cell|January 17, 2015
Identification and specification of the mouse skeletal stem cellCharles K F Chan, Eun Young Seo, James Y Chen, et al.
The Lancet. Neurology|July 29, 2018
Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational studyJeffrey J Bazarian, Peter Biberthaler, Robert D Welch, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
CD8<sup>+</sup> T cell recall cytotoxicity during chronic treated HIV-1 infection is associated with limited reservoir size and activityDavid R Collins, Mpho J Olatotse, Jonathan M Urbach, et al.
Blood Cancer Discovery|October 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor CellsAnnika Nelde, Heiko Schuster, Jonas S Heitmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 17, 2013
Clonal precursor of bone, cartilage, and hematopoietic niche stromal cellsCharles K F Chan, Paul Lindau, Wen Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced CancersBranimir I Sikic, Nehal Lakhani, Amita Patnaik, et al.
Pageof 6